Propofol/remifentanil patient-controlled sedation: caveat emptor!
- PMID: 37853278
- DOI: 10.1007/s12630-023-02592-2
Propofol/remifentanil patient-controlled sedation: caveat emptor!
Comment on
-
Propofol-remifentanil patient-controlled sedation for endoscopic procedures: a prospective service audit.Can J Anaesth. 2023 Nov;70(11):1735-1743. doi: 10.1007/s12630-023-02593-1. Epub 2023 Oct 9. Can J Anaesth. 2023. PMID: 37814120 English.
References
-
- Joy PJ, Blanshard HJ. Propofol-remifentanil patient-controlled sedation for endoscopic procedures. Can J Anesth 2023; https://doi.org/10.1007/s12630-023-02593-1 . - DOI - PubMed
-
- Edwards JA, Kinsella J, Shaw A, Evans S, Anderson KJ. Sedation for oocyte retrieval using target controlled infusion of propofol and incremental alfentanil delivered by non-anaesthetists. Anaesthesia 2010; 65: 453–61. https://doi.org/10.1111/j.1365-2044.2010.06264.x - DOI - PubMed
-
- Roback MG, Green SM, Andolfatto G, Leroy PL, Mason KP. Tracking and reporting outcomes of procedural sedation (TROOPS): standardized quality improvement and research tools from the International Committee for the Advancement of Procedural Sedation. Br J Anaesth 2018; 120: 164–72. https://doi.org/10.1016/j.bja.2017.08.004 - DOI - PubMed
-
- Mason KP, Roback MG, Chrisp D, et al. Results from the Adverse Event Sedation Reporting tool: a global anthology of 7952 records derived from >160,000 procedural sedation encounters. J Clin Med 2019; 8: 2087. https://doi.org/10.3390/jcm8122087 - DOI - PubMed - PMC
-
- Barends CR, Driesens MK, van Amsterdam K, Struys M, Absalom AR. Moderate-to-deep sedation using target-controlled infusions of propofol and remifentanil: adverse events and risk factors: a retrospective cohort study of 2937 procedures. Anesth Analg 2020; 131: 1173–83. https://doi.org/10.1213/ane.0000000000004593 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical